R, M., Y, I., S, K., K, S., D, Y., Y, T., . . . H, E. (2025). ASO Author Reflections: Efficacy of SOAT1 Inhibitors against Pancreatic Cancer with TP53 Mutations. Annals of surgical oncology, 32(9), 7088. https://doi.org/10.1245/s10434-025-17667-1
Chicago Style (17th ed.) CitationR, Maki, et al. "ASO Author Reflections: Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations." Annals of Surgical Oncology 32, no. 9 (2025): 7088. https://doi.org/10.1245/s10434-025-17667-1.
MLA (9th ed.) CitationR, Maki, et al. "ASO Author Reflections: Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations." Annals of Surgical Oncology, vol. 32, no. 9, 2025, p. 7088, https://doi.org/10.1245/s10434-025-17667-1.
Warning: These citations may not always be 100% accurate.